In addition to attenuating the abrupt release of pro-inflammatory cytokines, including TNF-α, IL-1β and IL-6, treatment with chlorogenic acid enhanced serum Th1 cytokines during the late phase of sepsis without affecting Th2 cytokine release (45). The gene discussed is TNF; the disease is Sepsis.